HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000046 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 2, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
120,000
Total Value
$3,557,836.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 19,000 | $65.36 | $1,241,802.00 | 768,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 1,000 | $65.71 | $65,714.00 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 15,800 | $64.06 | $1,012,195.40 | 771,980 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 4,200 | $64.89 | $272,525.40 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Apr 1, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 131,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Apr 2, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 111,923 | Direct | โ | View Details |